SCHEDULE: Bard Associates Discloses 5.6% Stake in Modular Medical, Inc.

Bard Associates Inc. has reported a 5.6% beneficial ownership stake in Modular Medical, Inc., holding 2,910,219 shares of common stock.

Summary

• Bard Associates Inc. has filed a Schedule 13G with the SEC, reporting beneficial ownership of common stock in Modular Medical, Inc.
• The filing indicates an aggregate beneficial ownership of 2,910,219 shares of Modular Medical, Inc. common stock.
• This stake represents 5.6% of the total outstanding common stock of Modular Medical, Inc.
• Bard Associates Inc. holds sole voting power and sole dispositive power over 205,481 shares.
• Additionally, Bard Associates Inc. has shared dispositive power over 3,115,700 shares.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Modular Medical, Inc.

Sentiment

Score: 6

Explanation: The filing is a standard disclosure of beneficial ownership by an investment adviser, indicating a significant stake in Modular Medical, Inc. This is generally a neutral to slightly positive signal as it shows institutional interest, but it does not contain performance data or strategic updates.

Positives

• The disclosure of a 5.6% beneficial ownership stake by Bard Associates Inc., an institutional investment adviser, signals significant institutional interest and potential confidence in Modular Medical, Inc.
• The filing explicitly states that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer, suggesting a passive investment strategy.

Negatives

• No specific negative financial or operational information is disclosed in this Schedule 13G filing, as its primary purpose is to report beneficial ownership.

Risks

• While not explicitly stated as a risk in the document, a significant ownership stake by a single entity, even if passive, could be perceived as a concentration risk by some investors.

Future Outlook

A Schedule 13G filing does not typically contain forward-looking statements or guidance regarding the issuer's future outlook.

Industry Context

This filing indicates an institutional investment adviser's interest in the medical device or healthcare sector, specifically Modular Medical, Inc. Such filings are common as institutional investors cross the 5% beneficial ownership threshold, signaling their positions in publicly traded companies.

Comparison to Industry Standards

• A 5.6% stake is a notable position for an institutional investor, often triggering a Schedule 13G filing. This level of ownership is typical for passive institutional investors who are not seeking to control the company but rather hold shares for investment purposes. No specific comparable companies or projects are mentioned in the document.

Stakeholder Impact

• Shareholders: The disclosure of a new significant institutional investor may enhance market confidence and potentially influence stock valuation positively.
• Management: The company's management will be aware of a new substantial shareholder, though the filing indicates no intent to influence control.

Key Dates

Keywords

Modular Medical Inc., Bard Associates Inc., Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Institutional Investor